SCHEMBL9988807

SCHEMBL9988807

O=C(Cc1ccnc(Cl)n1)c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HSD11B1 P28845 1/20 0.41
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
ERBB3 P21860 1/20 0.39
TEK Q02763 1/20 0.39
ERBB4 Q15303 1/20 0.39
SLC40A1 Q9NP59 2/20 0.39
PKM P14618 1/20 0.39
GLA P06280 1/20 0.39
BRAF P15056 2/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9989917 0.88 SLC40A1 (0.39) ALDH1A1SMN1; SMN2MEN1KMT2ASLC40A1
SCHEMBL2194305 0.87 SLC40A1 (0.43) SMN1; SMN2MEN1KMT2ASLC40A1BRAF
SCHEMBL2193388 0.87 SLC40A1 (0.38) ALDH1A1SMN1; SMN2MEN1KMT2AEGFR
SCHEMBL9989950 0.85 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MEN1KMT2AEGFR
SCHEMBL1640536 0.81 KCNQ3 (0.45) ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL1127143 0.80 SLC40A1 (0.46) SLC40A1BRAFHDAC3HDAC1HDAC7
SCHEMBL3422489 0.78 NPC1 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2APKM
SCHEMBL1127074 0.78 PKM (0.41) ALDH1A1SMN1; SMN2MEN1KMT2AHSD11B1
SCHEMBL9989300 0.78 SLC40A1 (0.39) ALDH1A1SMN1; SMN2MEN1KMT2AHSD11B1
SCHEMBL1127079 0.78 PKM (0.41) ALDH1A1SMN1; SMN2MEN1KMT2AHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110319392-A1 Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors GLAXOSMITHKLINE LLC 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319392-A1 Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors STK24, MAP3K5, MAP3K2 ALDH1A1 2613/4885SMN1; SMN2 2927/4885MEN1 3582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.